Cover Image

The efficacy and potential mechanisms of pyrotinib in targeting EGFR and HER2 in advanced oral squamous cell carcinoma

Abstract Background Human epidermal growth factor receptor 2 (HER2) plays an important role in the progression of multiple solid tumors and induces resistance to epidermal growth factor receptor (EGFR) target treatment. However, the expression status and the clinical significance of HER2 in oral squ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liang Zhou (Author), Kehao Le (Author), Qianming Chen (Author), Huiming Wang (Author)
Format:	Book
Published:	BMC, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
by: Wang C, et al.
Published: (2024)

A validated UPLC-MS/MS method for quantification of pyrotinib and population pharmacokinetic study of pyrotinib in HER2-positive breast cancer patients
by: Yunfang Zhu, et al.
Published: (2024)

Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies
by: Xiuwen Guan, et al.
Published: (2023)

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
by: Qiongwen Zhang, et al.
Published: (2023)

Trastuzumab-functionalized SK-BR-3 cell membrane-wrapped mesoporous silica nanoparticles loaded with pyrotinib for the targeted therapy of HER-2-positive breast cancer
by: Xing Liu, et al.
Published: (2024)

Her Gene Family As A Therapeutic Target In Oral Squamous Cell Carcinoma
by: Sana Mirza, et al.
Published: (2024)

Study of EGFR mutations in head and neck squamous cell carcinomas
by: Gurpreet Kaur, et al.
Published: (2021)

Differential effects of ketoconazole, fluconazole, and itraconazole on the pharmacokinetics of pyrotinib in vitro and in vivo
by: Li Wang, et al.
Published: (2022)

The Efficacy of Pyrotinib as a Third- or Higher-Line Treatment in HER2-Positive Metastatic Breast Cancer Patients Exposed to Lapatinib Compared to Lapatinib-Naive Patients: A Real-World Study
by: D. J Ouyang, et al.
Published: (2021)

Repurposing FDA Drug Compounds against Breast Cancer by Targeting EGFR/HER2
by: Irving Balbuena-Rebolledo, et al.
Published: (2021)

Case report: Pyrotinib and tegafur combined with radiotherapy achieved notable response in HER2-amplified rectal cancer with multiple metastases after multiline treatments
by: Peng Huang, et al.
Published: (2024)

Correlation of EGFR Expression with Survival Rate in Patients with Oral Squamous Cell Carcinoma
by: Fereshteh Baghai Naini, et al.
Published: (2017)

Case report: Successful treatment of a rare HER2-positive advanced breast squamous cell carcinoma
by: Gui Wang, et al.
Published: (2024)

Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition
by: Sun Qian, et al.
Published: (2011)

Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
by: Xiaolin Yu, et al.
Published: (2018)

The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
by: Hsiang-Ling Ho, et al.
Published: (2019)

Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer
by: Megha Jethwa, et al.
Published: (2024)

Prediction of pyrotinib exposure based on physiologically-based pharmacokinetic model and endogenous biomarker
by: Miao Zhang, et al.
Published: (2022)

Multiple Administrations of Itraconazole Increase Plasma Exposure to Pyrotinib in Chinese Healthy Adults
by: Liu Y, et al.
Published: (2021)

Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma
by: Chia-Hsien Shih, et al.
Published: (2024)

Recent advances of novel targeted therapy for squamous cell carcinoma of the head and neck
by: Jed A. Katzel, et al.
Published: (2011)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
by: Toyaja Jadhav, et al.
Published: (2024)

Molecular Targeting of Her-2/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus
by: Maryam Kouhsoltani, et al.
Published: (2015)

Prognostic significance of SOX2 for chemotherapeutic patients with oral squamous cell carcinoma
by: Xuefeng Zhang, et al.
Published: (2024)

HER2 as a prospective novel biomarker in squamous cell carcinomas of the head and neck
by: Antonio DAntonio, et al.
Published: (2018)

Resistance to Cetuximab in EGFR-Overexpressing Esophageal Squamous Cell Carcinoma Xenografts Due to FGFR2 Amplification and Overexpression
by: Yi Zhang, et al.
Published: (2014)

EGFR-IL-6 Signaling Axis Mediated the Inhibitory Effect of Methylseleninic Acid on Esophageal Squamous Cell Carcinoma
by: Yu Wang, et al.
Published: (2021)

EGFR Mutation in Nasopharyngeal Carcinoma
by: Evren Uzun, et al.
Published: (2022)

Oral squamous cell carcinoma: Advances in management
by: S M Balaji
Published: (2015)

Regulatory Mechanisms of lncRNAs and Their Target Gene Signaling Pathways in Laryngeal Squamous Cell Carcinoma
by: Wei Li, et al.
Published: (2020)

Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology
by: Jingjiang Lai, et al.
Published: (2022)

Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
by: Giulio Metro, et al.
Published: (2022)

EGFR-Targeted Photodynamic Therapy
by: Luca Ulfo, et al.
Published: (2022)

Blimp-1 Upregulation by Multiple Ligands via EGFR Transactivation Inhibits Cell Migration in Keratinocytes and Squamous Cell Carcinoma
by: Hyemin Lee, et al.
Published: (2022)

Role of EGFR Gene Polymorphisms in Oral Squamous Cell Carcinoma patients of Southeast of Iran: A Case-Control Study
by: Shirin Saravani, et al.
Published: (2020)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
by: Jieun Bang, et al.
Published: (2023)

Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line
by: Ranza Elrayess, et al.
Published: (2020)

Advanced Cervical Squamous Cell Carcinoma with Skin Metastasis
by: Chia-Hui Chen, et al.
Published: (2007)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
by: Xuanli Xu, et al.
Published: (2021)

HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population
by: Lulu Rong, et al.
Published: (2020)